ID

20821

Descripción

This study is a prospective, interventional, open-label, multi-center early access program for the use of Ra-223 Cl2 in HRPC/CRPC (Hormone refractory prostate cancer / Castrate resistant prostate cancer) patients diagnosed with bone metastasis and to collect additional short and long term safety data on the product. NCT01618370

Palabras clave

  1. 20/3/17 20/3/17 -
Subido en

20 de marzo de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Radium-223 Dichloride (Alpharadin) DRKS00006460 NCT01618370 in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases (End of Study Treatment)

Radium 223 Dichloride (Alpharadin) - End of Study Treatment

End of Study Treatment
Descripción

End of Study Treatment

Did the subject complete the treatment period?
Descripción

treatment period completed

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2732579
Primary reason for discontinuation of study treatment
Descripción

Primary reason for discontinuation of study treatment

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C0457454
UMLS CUI [1,3]
C1549995
If primary reason is "Adverse Event(s) not associated with clinical disease progression", give number(s). Up to 3 AE numbers can be entered:
Descripción

Dynamic search /ist contains: "Number - Term - Start Date"

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1444662
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0877248
If primary reason is "Withdrawal by subject (Consent withdrawn)",specify
Descripción

primary reason Consent withdrawn

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1549995
UMLS CUI [1,2]
C1707492
If primary reason is "Other",specify
Descripción

If primary reason is "Other",specify

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1549995
UMLS CUI [1,2]
C0205394
Subject entered active follow-up?
Descripción

Subject entered active follow-up?

Tipo de datos

text

Alias
UMLS CUI [1]
C0589120

Similar models

Radium 223 Dichloride (Alpharadin) - End of Study Treatment

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
End of Study Treatment
treatment period completed
Item
Did the subject complete the treatment period?
boolean
C2732579 (UMLS CUI [1])
Primary reason for discontinuation of study treatment
Item
Primary reason for discontinuation of study treatment
text
C0008976 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
C1549995 (UMLS CUI [1,3])
primary reason Adverse Event
Item
If primary reason is "Adverse Event(s) not associated with clinical disease progression", give number(s). Up to 3 AE numbers can be entered:
text
C1444662 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
primary reason Consent withdrawn
Item
If primary reason is "Withdrawal by subject (Consent withdrawn)",specify
text
C1549995 (UMLS CUI [1,1])
C1707492 (UMLS CUI [1,2])
If primary reason is "Other",specify
Item
If primary reason is "Other",specify
text
C1549995 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Subject entered active follow-up?
Item
Subject entered active follow-up?
text
C0589120 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial